Similar Articles
61 Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
62 Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
63 Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
64 Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
65 Shear wave elastography in hepatitis C patients before and after antiviral therapy
66 Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis
67 Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
68 Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data
69 Anti-hepatitis C virus drugs and kidney
70 Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA